Immunomodulation by Imiquimod in Patients with High-Risk Primary Melanoma-Reference-Cited by-同舟云学术

Immunomodulation by Imiquimod in Patients with High-Risk Primary Melanoma

Published:2012-01 Issue:1 Volume:132 Page:163-169
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Narayan Rupa,Nguyen Hong,Bentow Jason J.,Moy Lauren,Lee Diana K.,Greger Stephanie,Haskell Jacquelyn,Vanchinathan Veena,Chang Pei-Lin,Tsui Shanli,Konishi Tamiko,Comin-Anduix Begonya,Dauphine Christine,Vargas Hernan I.,Economou James S.,Ribas Antoni,Bruhn Kevin W.,Craft Noah

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference31 articles.

1. Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells;Barnetson;Clin Exp Dermatol,2004

2. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients;Buettiker;Arch Dermatol,2008

3. Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays;Comin-Anduix;Clin Cancer Res,2006

4. Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma;Comin-Anduix;J Transl Med,2008

5. Treatment of lentigo maligna with imiquimod before staged excision;Cotter;Dermatol Surg,2008

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor eradication by triplet therapy with BRAF inhibitor, TLR 7 agonist, and PD‐1 antibody for BRAF‐mutated melanoma;Cancer Science;2024-06-18

2. Vulvar Melanoma: Clinical Features, Diagnosis, Staging, Treatment and Prognosis;Clinical and Experimental Obstetrics & Gynecology;2024-01-08

3. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives;Frontiers in Immunology;2023-09-26

4. Advanced Acral Melanoma Therapies: Current Status and Future Directions;Current Treatment Options in Oncology;2022-09-20

5. The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma;Frontiers in Immunology;2022-09-05